M&A Deal Summary |
|
---|---|
Date | 2024-05-21 |
Target | Baxter Planning |
Sector | Internet Software and Services |
Buyer(s) | Marlin Equity Partners |
Sellers(s) | Polaris Partners |
Deal Type | Secondary Buyout |
Advisor(s) | Guggenheim Securities (Financial) Morris, Manning & Martin (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 2005 |
PE ASSETS | 8.5B USD |
Size | Mega |
Type | Sector Agnostic |
Marlin Equity Partners is a private investment firm focused on acquiring distressed businesses with sales of $10 million to $2 billion. Marlin has a special interest in non-core or underperforming divisions of larger corporations, as well as companies facing some sort of financial, operational or market-related transition. Marlin is a generalist investor and will consider opportunities in technology (software, IT, payment systems, hardware, communications, internet), healthcare, consumer (apparel, retail, consumer products, food/beverage), services (business, financial, consumer, education), manufacturing (automotive, industrial, metals, plastics), aerospace, defense, and media. Marlin prefers businesses with scalable business models, strong installed customer bases, defensible market positions, and barriers to entry. Marlin Equity Partners was formed in 2005 and is based in Hermosa Beach, California with an additional office in London.
DEAL STATS | # |
---|---|
Overall | 115 of 116 |
Sector (Internet Software and Services) | 40 of 40 |
Type (Secondary Buyout) | 22 of 22 |
State (Texas) | 13 of 13 |
Country (United States) | 83 of 83 |
Year (2024) | 3 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2024-05-06 |
Inkling
San Francisco, California, United States Inkling is an enterprise software platform for field operations management that helps customers drive superior operating performance. As more businesses put mobile devices in the hands of their field teams, the company's mission is to transform and improve the way field teams operate. With two complementary products that allow end-to-end delivery of both content and tasks, Inkling's platform drives increased success in the field while providing new levels of visibility into critical operating metrics. Inkling was founded in 2009 and is based in San Francisco, California. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2024-09-16 |
Challenger
Arlington, Virginia, United States Challenger is a global performance improvement platform that delivers a comprehensive portfolio of solutions focused on sales marketing and customer service training through in-person workshops, eLearning and workflow tools, diagnostic and assessment offerings, and other sales acceleration modules. Underpinned by the world-renowned, research-based Challenger and Effortless Experience methodologies, its solutions help enterprises adopt, develop, communicate, and implement more effective commercial strategies on a global scale. Challenger was founded in 1979 and is based in Arlington, Virginia. |
Sell | - |
Category | Growth Capital Firm |
---|---|
Founded | 1996 |
PE ASSETS | 5.0B USD |
Size | Large |
Type | Sector Agnostic |
Polaris Partners is primarily a seed, first round, and early stage venture capital investor in information technology and life science businesses. However, Polaris also focuses on private equity investments in established companies. In this area, Polaris targets high growth middle market companies in industries including technology, healthcare, digital media, consumer products and services, and business services. The firm's investments include minority growth equity investments, recapitalizations with liquidity, and leveraged buyouts. Polaris Partners was formed in 1996 and has offices in Seattle, Washington and Waltham, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 31 of 33 |
Sector (Internet Software and Services) | 5 of 5 |
Type (Secondary Buyout) | 9 of 9 |
State (Texas) | 4 of 4 |
Country (United States) | 29 of 30 |
Year (2024) | 2 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2024-01-30 |
Tectonic Therapeutic /old/
Watertown, Massachusetts, United States Tectonic Therapeutic aims to transform the discovery of novel drugs addressing targets in the GPCR family. Tectonic Therapeutic was founded in 2019 and is based in Watertown, Massachusetts. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2024-08-01 |
Jnana Therapeutics
Boston, Massachusetts, United States Jnana Therapeutics is developing drugs against a broad family of metabolite transport proteins to treat high unmet needs in auto-immune, immuno-metabolism, and other diseases. Jnana Therapeutics was founded in 2017 and is based in Boston, Massachuserrs. |
Sell | $800M |